2-(4-morpholinyl)-4h-1-benzopyran-4-one has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aebi, JD; Berger, Y; Blum-Kaelin, D; Dehmlow, H; Juillerat-Jeanneret, L; Kitas, EA; Löffler, BM | 1 |
1 other study(ies) available for 2-(4-morpholinyl)-4h-1-benzopyran-4-one and Glioblastoma
| Article | Year |
|---|---|
Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells.
Topics: Antineoplastic Agents; Aspartic Acid Endopeptidases; Carbamates; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Drug Screening Assays, Antitumor; Endothelin-1; Endothelin-Converting Enzymes; Glioblastoma; Humans; Hydrazines; Metalloendopeptidases; Proline; Pyrimidines; Pyrrolidines; Structure-Activity Relationship; Sulfhydryl Compounds | 2005 |